{"id":5361,"date":"2019-09-06T15:23:34","date_gmt":"2019-09-06T14:23:34","guid":{"rendered":"https:\/\/www.argonandco.com\/life-sciences\/"},"modified":"2025-02-11T12:52:19","modified_gmt":"2025-02-11T12:52:19","slug":"life-sciences","status":"publish","type":"page","link":"https:\/\/www.argonandco.com\/us\/industries\/life-sciences\/","title":{"rendered":"Life sciences"},"content":{"rendered":"

Life sciences<\/h2>\n

Historically highly profitable, the life sciences industry is now undergoing accelerated change in a context of economic pressure, increasing regulatory requirements, price\/service competitivity on OTC products, deregulation and the rationalization of public health devices.<\/p>\n

Challenges in the life sciences industry<\/h2>\n

Facing these evolutions, pharmaceutical laboratories must continually improve service to their customers through the development\/launch of new products or their improvement, and the development of service to the patient and the prescribers, taking advantage of digital capabilities.<\/p>\n

Laboratories must also continue to look for scale effects to reduce increasing costs of R&D through industrial or distribution synergies. Acquisitions must be integrated effectively, particularly concerning organizational structure, processes and IT.<\/p>\n

Life science companies need to be increasingly flexible while controlling costs; adapting the distribution strategy, improving demand steering and the collaboration model through controlling the balance between demand, inventory and industrial capacity, evolving the industrial model (decoupling points, delayed differentiation, campaign size), stock policy optimization, production cycle reduction and the management of change controls.<\/p>\n

How we can help with life science challenges<\/h2>\n

We help life science companies transform, from operations assessment to the implementation of improvement initiatives throughout the supply chain.<\/p>\n

\n
\n
\n

Operations strategy<\/h4>\n
<\/div>\n <\/div>\n
\n